Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3

類似資料

• Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120)
  著者:: Dhodapkar, Madhav V., 等
  出版事項: (2014)
• Reiterative Survival Analyses of Total Therapy 2 for Multiple Myeloma Elucidate Follow-Up Time Dependency of Prognostic Variables and Treatment Arms
  著者:: Barlogie, Bart, 等
  出版事項: (2010)
• Risk factors for MDS and acute leukemia following total therapy 2 and 3 for multiple myeloma
  著者:: Usmani, Saad Z., 等
  出版事項: (2013)
• Total Therapy 3 for multiple myeloma: prognostic implications of cumulative dosing and premature discontinuation of VTD maintenance components, bortezomib, thalidomide, and dexamethasone, relevant to all phases of therapy
  著者:: van Rhee, Frits, 等
  出版事項: (2010)
• Standard and novel imaging methods for multiple myeloma: correlates with prognostic laboratory variables including gene expression profiling data
  著者:: Waheed, Sarah, 等
  出版事項: (2013)